CHMP Recommends First Herceptin Biosimilar, 12 Other Medicines for EU Approval

Drug Industry Daily
A A
The European Medicines Agency’s Committee for Medicinal Products for Human Use recommended thirteen products, including its first biosimilar for Genentech’s blockbuster drug Herceptin.

To View This Article:

Login

Subscribe To Drug Industry Daily